2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide

C45H79N11O14S — CID 134368599

IUPAC2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide
SMILESCC(=O)NC(CSC1CC(=O)N(CCCCN2C[C@H](O)[C@@H](O)[C@H](O)[C@H]2CO)C1=O)C(=O)NC(CCCCN)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(C)=O
InChIInChI=1S/C45H79N11O14S/c1-25(2)18-31(27(4)58)54-43(68)30(13-7-9-15-47)52-41(66)26(3)50-37(62)21-48-36(61)20-49-42(67)29(12-6-8-14-46)53-44(69)32(51-28(5)59)24-71-35-19-38(63)56(45(35)70)17-11-10-16-55-22-34(60)40(65)39(64)33(55)23-57/h25-26,29-35,39-40,57,60,64-65H,6-24,46-47H2,1-5H3,(H,48,61)(H,49,67)(H,50,62)(H,51,59)(H,52,66)(H,53,69)(H,54,68)/t26?,29?,30?,31?,32?,33-,34+,35?,39-,40-/m1/s1
InChIKeyVWQMYEJMRHJKBB-WCDWYMGWSA-N
MW1030.26 g/mol
LogP-5.02
Rot. Bonds33

About 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide

2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide (PubChem CID 134368599) has the molecular formula C45H79N11O14S and a molecular weight of 1030.26 g/mol. Its IUPAC name is 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide.

Molecular Properties

Compound Name2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide
PubChem CID134368599
Molecular FormulaC45H79N11O14S
Molecular Weight1030.26 g/mol
Exact Mass1029.55
IUPAC Name2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide
SMILESCC(=O)NC(CSC1CC(=O)N(CCCCN2C[C@H](O)[C@@H](O)[C@H](O)[C@H]2CO)C1=O)C(=O)NC(CCCCN)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(C)=O
InChIInChI=1S/C45H79N11O14S/c1-25(2)18-31(27(4)58)54-43(68)30(13-7-9-15-47)52-41(66)26(3)50-37(62)21-48-36(61)20-49-42(67)29(12-6-8-14-46)53-44(69)32(51-28(5)59)24-71-35-19-38(63)56(45(35)70)17-11-10-16-55-22-34(60)40(65)39(64)33(55)23-57/h25-26,29-35,39-40,57,60,64-65H,6-24,46-47H2,1-5H3,(H,48,61)(H,49,67)(H,50,62)(H,51,59)(H,52,66)(H,53,69)(H,54,68)/t26?,29?,30?,31?,32?,33-,34+,35?,39-,40-/m1/s1
InChIKeyVWQMYEJMRHJKBB-WCDWYMGWSA-N
XLogP-5.02
TPSA394.35 Ų
H-Bond Donors13
H-Bond Acceptors18
Rotatable Bonds33
Heavy Atoms71
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001030.26
LogP ≤ 5-5.02
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide?
The IUPAC name of 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide (CID 134368599) is 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide.
What is the SMILES notation for 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide?
The canonical SMILES for 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide is CC(=O)NC(CSC1CC(=O)N(CCCCN2C[C@H](O)[C@@H](O)[C@H](O)[C@H]2CO)C1=O)C(=O)NC(CCCCN)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(C)=O.
What is the InChIKey of 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide?
The InChIKey is VWQMYEJMRHJKBB-WCDWYMGWSA-N. The full InChI is InChI=1S/C45H79N11O14S/c1-25(2)18-31(27(4)58)54-43(68)30(13-7-9-15-47)52-41(66)26(3)50-37(62)21-48-36(61)20-49-42(67)29(12-6-8-14-46)53-44(69)32(51-28(5)59)24-71-35-19-38(63)56(45(35)70)17-11-10-16-55-22-34(60)40(65)39(64)33(55)23-57/h25-26,29-35,39-40,57,60,64-65H,6-24,46-47H2,1-5H3,(H,48,61)(H,49,67)(H,50,62)(H,51,59)(H,52,66)(H,53,69)(H,54,68)/t26?,29?,30?,31?,32?,33-,34+,35?,39-,40-/m1/s1.
What are the key properties of 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide?
2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide has a molecular weight of 1030.26 g/mol, XLogP of -5.02, 33 rotatable bonds, 13 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[[2-[[2-[[2-[[2-acetamido-3-[2,5-dioxo-1-[4-[(2R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]butyl]pyrrolidin-3-yl]sulfanylpropanoyl]amino]-6-aminohexanoyl]amino]acetyl]amino]acetyl]amino]propanoylamino]-6-amino-N-(5-methyl-2-oxohexan-3-yl)hexanamide is sourced from PubChem (CID 134368599), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).